Serge Saxonov is the Chief Executive Officer at 10x Genomics Inc Class A, a company at the forefront of revolutionizing scientific research through innovative genomic tools. Saxonov's career is marked by significant contributions to the field of biotechnology and genomics. Before joining 10x Genomics, he held pivotal roles that shaped his expertise and leadership in the industry. Notably, he was a key figure at Illumina, Inc., where he served as Vice President of Corporate and Business Development. His tenure at Illumina allowed him to spearhead strategic initiatives and partnerships that propelled the company's growth and solidified its position as a leader in genomic sequencing. At 10x Genomics, Saxonov has been instrumental in steering the company towards its mission of advancing human health through a deeper understanding of biology. Under his leadership, 10x Genomics has developed groundbreaking technologies such as the Chromium and Visium platforms, which enable researchers to conduct single-cell and spatial genomic analyses with unprecedented resolution. These innovations have not only expanded the company's product portfolio but have also significantly impacted the scientific community by facilitating discoveries in fields ranging from oncology to immunology. Saxonov's strategic vision and commitment to excellence have been pivotal in establishing 10x Genomics as a trailblazer in the genomics industry. In addition to his role at 10x Genomics, Serge Saxonov is recognized for his thought leadership and contributions to the broader scientific community. He frequently speaks at industry conferences and contributes to discussions on the future of genomics and its potential to transform healthcare. His leadership style emphasizes collaboration and innovation, fostering an environment where cutting-edge research can thrive. Saxonov's dedication to advancing genomic science, combined with his extensive experience in biotechnology, continues to drive 10x Genomics forward as it seeks to unlock new possibilities in human health and disease research.